What Alaska Found
The people who ended up in Anchorage emergency rooms were not there because of a sexually transmitted infection. They were there because their joints hurt.
In April 2024, an infectious disease physician alerted Alaska's Section of Epidemiology to a rise in suspected cases of disseminated gonococcal infection among patients seeking care for joint pain. A review of state surveillance data found the increase had begun in July 2023.
The resulting CDC report, published July 16, identified 35 cases across 2023 and 2024. That compares with three cases in 2022. In 2024 alone, 27 cases represented 1.3 percent of the state's 2,079 reported gonorrhea infections, roughly 3.7 times the rate in 2023 and 10 times the rate in 2022.
Disseminated gonococcal infection, or DGI, happens when the bacterium that causes gonorrhea enters the bloodstream and spreads beyond its original site. It occurs in fewer than 1 percent of reported gonorrhea cases, which is precisely why it is missed.
What it does when it spreads is serious. Among the 35 patients, 60 percent developed septic arthritis, 37 percent had fever, 34 percent had pain across multiple joints, and 11 percent had skin lesions. Three developed endocarditis, an infection of the heart valves. Nearly 89 percent required hospitalization and 57 percent needed surgery, including 18 joint procedures and two heart valve replacements. No one in this group died.
Why Most Patients Had No Genital Symptoms
The single most important finding for readers is the one that breaks the mental model most people carry about STIs.
Eighty percent of these patients had no urogenital, throat or rectal symptoms at the time of diagnosis. There was nothing to notice, nothing to prompt a test, and no reason for the patient to connect a swollen knee to sexual health.
That is not unusual for gonorrhea. Many infections produce no symptoms at all, particularly in the throat. The CDC report notes that pharyngeal gonorrhea, which is often silent, appears to be a possible predisposing factor for the infection spreading.
The report also observes that many patients did not belong to the groups for whom routine gonorrhea screening is recommended, such as sexually active women under 25. They were not being screened, they had no symptoms, and the first sign anything was wrong was joint pain or a rash weeks later.
The report's guidance to clinicians is direct: "Clinicians should maintain a high index of suspicion for DGI" in patients at risk, even without mucosal symptoms.
The Testing Gap That Delays Diagnosis
There is a technical detail here that patients can act on, and it explains how someone can be told they do not have gonorrhea when they do.
Gonorrhea testing is site-specific. A urine test checks the urogenital tract. It does not detect an infection in the throat or rectum, and those require their own swabs.
Among the Alaska patients who had urogenital specimens collected, 40 percent tested negative there despite having disseminated infection confirmed elsewhere. A negative urine test is not a clean bill of health if the exposure was oral or anal.
CDC treatment guidelines call for collecting specimens from all mucosal sites of sexual exposure, in addition to the affected joint or blood, when DGI is suspected. The report notes that missed opportunities for mucosal testing may contribute to missed cases.
The practical translation for a patient: if you are being tested and your sexual history includes oral or anal exposure, ask specifically whether throat and rectal swabs are being collected. Many clinics do not do this by default.
Who This Actually Affects
Reporting this accurately matters, because the easy version of this story would stigmatize the wrong people and reassure the wrong people.
The Alaska patients spanned demographic groups. Median age was 36. Roughly half were male and half female. Among those whose sexual identity was recorded, most identified as heterosexual. Cases occurred across racial and ethnic groups, with 71 percent living in Anchorage County.
Thirty-seven percent had a documented substance use disorder, and other conditions appeared in smaller numbers, including hepatitis C in 14 percent and diabetes in 9 percent. Those are real findings, but they do not define the at-risk group.
Elizabeth Ohlsen, one of the state physicians involved, put it plainly in comments to Alaska Public Media about the broader rise, saying the risk is not confined to one group but instead involves "more sexually active people who have multiple partners" or whose partner does.
In response to the investigation, Alaska broadened its gonorrhea screening recommendations to include all sexually active patients with risk factors including substance use, multiple partners, or a history of sexually transmitted infections.
One reassuring laboratory finding: every isolate tested remained susceptible to ceftriaxone, the first-line treatment. Researchers did identify a cluster of eight closely related isolates carrying a sequence type not previously reported in the United States, along with a genetic marker associated with the bacterium's ability to spread, so the strain question is unresolved even though treatment still works.
What to Do
The actions here are ordinary, and that is the point.
Get tested if you are sexually active with new or multiple partners, and ask for testing at all sites of exposure rather than a urine test alone. Testing is available at primary care offices, sexual health clinics, Planned Parenthood locations, and many county health departments, frequently at low or no cost regardless of insurance.
If you are diagnosed, complete the entire treatment course even after symptoms resolve, and make sure partners are notified and treated. Untreated infection is the pathway to everything described above. Most health departments will help notify partners anonymously if that is easier.
Contact a clinician promptly for a swollen, hot, or painful joint that comes on over days without an injury, especially with fever, pain in several joints at once, or a rash with small pustules on the arms or legs. Say directly that you would like gonorrhea considered. It is an awkward sentence, and it can delay a diagnosis by weeks.
Seek emergency care for a single severely painful joint you cannot use, high fever with confusion, chest pain, or shortness of breath. Septic arthritis and endocarditis are emergencies.
Nothing here means a sore knee is an STI. Joint pain has many ordinary causes. It means this cause exists, is treatable, and is routinely overlooked because patients and clinicians alike are not thinking about it.
The confirmed finding is 35 cases in Alaska across two years against three in 2022, with 80 percent lacking genital symptoms. Those most affected are sexually active adults across demographic groups, particularly anyone whose exposure was oral or anal and who tested negative on urine alone. The reasonable action is site-specific testing and completing treatment. The central uncertainty is whether the novel strain cluster spreads beyond Alaska. The next expected development is further state surveillance reporting.
Frequently Asked Questions
What is disseminated gonococcal infection? It occurs when gonorrhea bacteria enter the bloodstream and spread beyond the original site, reaching joints, skin, and occasionally the heart valves. It affects fewer than 1 percent of reported cases.
What are the signs? Septic arthritis was most common at 60 percent of Alaska patients, followed by fever, pain across multiple joints, tendon inflammation, and skin lesions.
Can you have it without genital symptoms? Yes. Eighty percent of the Alaska patients had no urogenital, throat, or rectal symptoms when diagnosed.
Does a negative urine test rule out gonorrhea? No. Testing is site-specific. Forty percent of Alaska patients tested at urogenital sites were negative there despite confirmed infection elsewhere.
What should I ask for when getting tested? Ask whether throat and rectal swabs are being collected if your exposures included oral or anal sex. Many clinics do not do this automatically.
Is it treatable? Yes. Every isolate tested in this report remained susceptible to ceftriaxone, the first-line antibiotic. Most patients required hospitalization for intravenous treatment.
When should I go to an emergency room? For a single severely painful joint you cannot use, high fever with confusion, chest pain, or shortness of breath.
